MAP3K5 and Alzheimer disease: The outcome is mitochondrial apoptosis through activation of ASK1, downstream JNK and mitogen-activated protein kinase (MAPK14) signalling pathways [145], which lead to reduced inflammatory response and tumorigenesis or the initiating of neurodegenerative disorders, such as AD [137,142].